Abstract. Measuring distribution of dissolved oxygen in biological tissue is of prime interest for cancer diagnosis, prognosis, and therapy optimization. Tumor hypoxia indicates poor prognosis and resistance to radiotherapy. Despite its major clinical significance, no current imaging modality provides direct imaging of tissue oxygen. We present preliminary results demonstrating the potential of photoacoustic lifetime imaging ͑PALI͒ for noninvasive, 3-D imaging of tissue oxygen. The technique is based on photoacoustic probing of the excited state lifetime of methylene blue ͑MB͒ dye. MB is an FDA-approved water soluble dye with a peak absorption at 660 nm. A double pulse laser system ͑pump probe͒ is used to excite the dye and probe its transient absorption by detecting photoacoustic emission. The relaxation rate of MB depends linearly on oxygen concentration. Our measurements show high photoacoustic signal contrast at a probe wavelength of 810 nm, where the excited state absorption is more than four times higher than the ground state absorption. Imaging of a simple phantom is demonstrated. We conclude by discussing possible implementations of the technique in clinical settings and combining it with photodynamic therapy ͑PDT͒ for real-time therapy monitoring.
The balance of oxygen delivery and consumption in tissue is altered by disease processes resulting in change of tissue O 2 level ͑pO 2 ͒ and its spatial distribution. In the case of cancer, for example, tumor growth promotes an increased level of oxygen consumption. The new demand is partially compensated by the formation of new blood vessels ͑angiogenesis͒. However, the irregular nature of cancer progression results in large variability in tissue pO 2 , since tumor regions close to blood vessels are well perfused, while other regions lack oxygen supply and become hypoxic. 1, 2 Because of the important role oxygen plays in cancer biology and tumor progression, imaging of pO 2 distribution in tissue can significantly improve cancer screening, cancer diagnosis, therapy planning, and therapy monitoring. This challenge had motivated and driven an extensive effort in developing new tissue oxygen imaging methods. Modalities such as positron emission tomography ͑PET͒, 3 blood oxygen level dependent functional magnetic resonance imaging ͑BOLD-MRI͒, 4 and fluorescence imaging 5 have been modified to yield pO 2 -related imaging. However, implementation of these methods in clinical settings is not common due to inherent limitations. BOLD-MRI is only sensitive to blood oxygenation. PET agents indicate activity of cell metabolism, which is only indirectly related to oxygen contents in the tissue. Phosphorescence imaging cannot resolve depth and therefore is not applicable to tissue imaging. There is clearly a strong and unsatisfied clinical need for a tissue oxygen imaging modality.
Recently we proposed photoacoustic lifetime imaging ͑PALI͒ as a pump-probe photoacoustic technique for noninvasive, 3-D tissue oxygen imaging. 6 The technique relies on photoacoustic measurement of the lifetime of an oxygensensitive dye-excited state. A metal core porphyrin dye ͓Pt͑II͒ octaethylporphine, PtOEP͔ was successfully used for oxygen sensing. However, with the excitation wavelength in the range of 500 to 540 nm, PtOEP limits penetration depth in tissue to less than 3 mm.
We present here a new implementation of a technique using Methylene blue ͑MB͒ as an oxygen sensitive agent. MB is an FDA-approved, water soluble dye. It has a strong absorption peak at 660 nm ͑extinction coefficient is 72,000 cm −1 / M͒. At this wavelength, tissue optical absorption is relatively low, allowing imaging at a larger penetration depth.
MB has a high quantum yield for triplet state transition and a long triplet lifetime of 79.5 s in a degassed water solution. 7 In air-saturated aqueous solution, the lifetime drops sharply to less than 2 s. The reduced lifetime results from efficient energy transfer to oxygen molecules and formation of singlet oxygen. This makes MB a good photosensitizer for photodynamic therapy ͑PDT͒. Its use in PDT had been studied for several clinical applications. [8] [9] [10] The main advantage of MB as a PDT agent is its efficient topical administration, eliminating skin photosensitivity, one of the side effects of PDT. 11 The same features make MB suitable for tissue oxygen monitoring by PALI. PALI employs photoacoustic imaging to map tissue optical absorption by detection of an acoustic field emitted by thermoelastic expansion induced by a laser pulse. 12 In PALI, an excitation pulse of a different wavelength is first applied to excite the dye at a specified time interval before the photoacoustic imaging pulse is fired. This enables photoacoustic probing of tissue absorption at a specified delay after excitation. Repeating it for multiple excitation-probe delay times yields transient absorption data, enabling pixel-by-pixel reconstruction of the excited state lifetime within the imaging volume. In conjunction with oxygen-sensitive dye such as MB, the technique is capable of producing tissue oxygen distribution noninvasively in a 3-D volume. Imaging depth depends mostly on the penetration depth of the excitation light in tissue.
We have designed experiments to test PALI in simple phantom objects containing either one or two dye-filled plastic tubings. The experimental setup used in our measurements is shown in Fig. 1 . The excitation pulse is generated by an optical parametric oscillator ͑OPO, Magic prism Opotek, Carlsbad, California͒ pumped by a tripled NdYAG pulsed laser ͑Surelite I-10, Coherent, Santa Clara, California͒. The OPO system allows tunability of the excitation pulse wavelength in the range of 480 to 680 nm. In all experiments described here, the excitation wavelength is 650 nm. A second pulsed-laser OPO system is used for photoacoustic probing ͑Opotek Rainbow͒. The second OPO system is tunable in the range of 700 to 960 nm. The relative time delay between pump and probe laser firing is controlled by a programmable logic array ͑KNJN Saxo FX2 FPGA, California͒. The output of both OPO systems is coupled to two branches of a Y-branched light guide ͑Edmund Optics, York, United Kingdom͒. The common port of the branched light guide is connected to an additional liquid-filled flexible light guide to ensure uniform and equal distribution of the two beams across the illumination aperture. The output from the liquid light guide is directed to illuminate the MB-filled tubing phantom ͑Tygon, Paris, France, ID= 0.7 mm, OD= 2 mm͒. MB dye is circulated in the tubing by a peristaltic pump ͑Masterflex 77300-50, Vernon Hills, Illinois͒. Oxygen concentration is controlled by bubbling either nitrogen or an air-nitrogen mixture in a cell connected in-line with the flow circulation system. Oxygen level is measured independent of PALI measurements by oxygen electrode ͑microelectrodes, part 16-732͒. The phantom is immersed in a water tank, and an ultrasound transducer ͑GE Panametrics, V311, 10 MHz, f# =2͒ is used for detecting photoacoustic signals. Signals are amplified by an electronic amplifier ͑JSR Ultrasonics, Pittsford, New York, model DPR300͒, recorded by a digital oscilloscope ͑Lecroy Wavejet 354, Chestnut Ridge, New York͒, and transferred to a computer for processing. A motorized actuator ͑Zaber Technologies T-LA28, Vancouver, British Columbia͒ and a linear stage ͑Thorlabs PT3, Pittsburgh, Pennsylvania͒ are used for scanning the ultrasound transducer in a direction perpendicular to the tubing's axis.
In a first set of measurements, single tubing was installed. A dye solution of 0.3-mM MB in phosphate buffered saline ͑PBS͒ solution ͑pH= 7.4͒ was prepared. The solution was then circulated in the tubing system. A constant pO 2 was maintained by controlling the ratio of N 2 to air-gas bubbling rate in the oxygen control cell. The probe laser system was tuned to 810 nm. The optical fluence at the object location of the pump and probe beams was 1.8 and 2.5 mJ/ cm 2 , respectively. We have measured the generated photoacoustic ͑PA͒ signal at a range of pump-probe time delays. The probe photoacoustic signal was evaluated by first subtracting a signal measured with only the pump laser operating from a signal measured with both the pump and probe lasers on. The signal energy is quantified by integrating the square of the signal amplitude. PA signal energy as a function of pump-probe delay time is given in Fig. 2 for four different pO 2 values. A fit-to-exponential decay is performed for each set of measurements. The decay rate ͑1/lifetime͒ is plotted as a function of the oxygen level ͑see Fig. 2 inset͒. The relationship of decay rate to pO 2 is well described by linear dependence.
A basic imaging experiment was performed by installing two plastic tubings in the flow system, where each is controlled for a different pO 2 value ͑set values are 150 and 10 mmHg͒. The ultrasound transducer was scanned vertically in a range of 10 mm. The step size of the scan was 0.2 mm. At each step a sequence of PA signal acquisitions was conducted. First a background signal with only the pump laser operating was recorded. Then a series of signals was recorded at a range of pump-probe delay values. Raw PA signals were processed by first subtracting the pump-only ͑background͒ signal, and then applying a low-pass filter ͑eighth-order Chebishev I, cut off at 6.25 MHz͒ and envelope detection by the Hilbert transform method. A complete set of processed scanned signals is then combined to yield a PA image. The process is repeated for each value of pump-probe delay. A sample of a PA image at a pump-probe delay of 1 s is shown in Fig. 3 ͑bottom͒. The image depicts mostly the front and back interfaces of each tube. The annotated circles on the image represent the actual location and size of the inner part of the tubes. A total of 5 PA images were calculated in the same way, corresponding to pump-probe delays of 1, 3, 6, 10, In conclusion, we present preliminary experiments demonstrating a PALI technique for oxygen imaging using MB as an oxygen sensor. Our measurements show that the MB excitation lifetime can be measured by photoacoustics, and the decay rate of the excited state depends linearly on oxygen partial pressure. The technique is suitable for measuring oxygen levels within the physiological range of pO 2 from 0 to 100 mmHg. A basic imaging setup was tested for imaging a simple phantom containing two tubes of different pO 2 . The pO 2 image correctly reflects the high and low oxygen levels in the tubes; however, significant deviations from the actual values and large scatter is encountered in the quantitative pO 2 image. These errors can be attributed to fluctuations in the pulse energy of both the pump and probe lasers. A correction mechanism for normalizing the measured signals by the actual pulse energy will be considered for improving the image accuracy.
Translating this method to clinical applications in cancer would be extremely valuable for accurate prognosis and therapy planning. However, applying this method in a biological environment requires further investigations. A competing process of triplet quenching by electron transfer and radical formation can result in overestimation of pO 2 . The relative contribution of this process increases in low pH environments. 11 These effects should be addressed in future testing and development of the PALI technique. 
